DE69731097D1 - Conotoxin peptid pviia - Google Patents

Conotoxin peptid pviia

Info

Publication number
DE69731097D1
DE69731097D1 DE69731097T DE69731097T DE69731097D1 DE 69731097 D1 DE69731097 D1 DE 69731097D1 DE 69731097 T DE69731097 T DE 69731097T DE 69731097 T DE69731097 T DE 69731097T DE 69731097 D1 DE69731097 D1 DE 69731097D1
Authority
DE
Germany
Prior art keywords
cys
conotoxin
peptide
kappa
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69731097T
Other languages
English (en)
Other versions
DE69731097T2 (de
Inventor
Heinrich Terlau
Ki-Joon Shon
M Grilley
M Olivera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
University of Utah Research Foundation UURF
Original Assignee
MAX PLANCK INST fur EXPERIMEN
University of Utah Research Foundation UURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAX PLANCK INST fur EXPERIMEN, University of Utah Research Foundation UURF filed Critical MAX PLANCK INST fur EXPERIMEN
Application granted granted Critical
Publication of DE69731097D1 publication Critical patent/DE69731097D1/de
Publication of DE69731097T2 publication Critical patent/DE69731097T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69731097T 1996-03-18 1997-03-14 Conotoxin Peptide PVIIA Expired - Lifetime DE69731097T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/619,936 US5672682A (en) 1996-03-18 1996-03-18 Conotoxin peptide PVIIA
US619936 1996-03-18
PCT/US1997/003483 WO1997034925A1 (en) 1996-03-18 1997-03-14 Conotoxin peptide pviia

Publications (2)

Publication Number Publication Date
DE69731097D1 true DE69731097D1 (de) 2004-11-11
DE69731097T2 DE69731097T2 (de) 2005-02-17

Family

ID=24483913

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731097T Expired - Lifetime DE69731097T2 (de) 1996-03-18 1997-03-14 Conotoxin Peptide PVIIA

Country Status (9)

Country Link
US (1) US5672682A (de)
EP (1) EP0922055B1 (de)
JP (1) JP3953110B2 (de)
AT (1) ATE278708T1 (de)
AU (1) AU724408B2 (de)
CA (1) CA2248710C (de)
DE (1) DE69731097T2 (de)
ES (1) ES2232861T3 (de)
WO (1) WO1997034925A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010001652A1 (en) * 1997-01-14 2001-05-24 Shuichi Kanno Process for treating flourine compound-containing gas
WO2000020018A1 (en) * 1998-10-06 2000-04-13 Cognetix, Inc. Kappa-a conopeptides and uses therefor
US6797808B1 (en) * 1999-01-29 2004-09-28 University Of Utah Research Foundation α-conotoxin peptides
CA2361534C (en) * 1999-01-29 2011-08-30 University Of Utah Research Foundation Alpha-conotoxin peptides
JP2002536970A (ja) * 1999-02-04 2002-11-05 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション タウ−コノトキシン・ペプチド
DE60028787T2 (de) 1999-08-10 2007-06-06 Uab Research Foundation, Birmingham Methode zur behandlung von verletzungen des traumatisierten gehirns mit nicht-steroid entzündungshemmenden medikamenten
AU778182B2 (en) * 1999-09-22 2004-11-18 Cognetix, Inc. Uses of kappa-conotoxin PVIIA
CA2396529A1 (en) 1999-12-30 2001-07-12 University Of Utah Research Foundation O-superfamily conotoxin peptides
JP2005532260A (ja) * 2002-01-29 2005-10-27 コグネティックス・インコーポレイテッド 器官保護剤としてのカッパ−ｐｖｉｉａ−関連コノトキシン
US6958151B2 (en) * 2002-03-15 2005-10-25 Board Of Regents, The University Of Texas System Miniprotein ligands and other polypeptides and methods for making and using same
AU2003263853A1 (en) * 2002-08-16 2004-03-03 Board Of Regents The University Of Texas System Compositions and methods related to flavivirus envelope protein domain iii antigens
US20050137132A1 (en) * 2002-09-20 2005-06-23 University Of Utah Research Foundation Uses of novel potassium channel blockers
US20040229780A1 (en) * 2002-09-20 2004-11-18 Olivera Baldomero M. KappaM-conopeptides as organ protectants
US20060178303A1 (en) * 2004-09-09 2006-08-10 University Of Utah Research Foundation Potassium channel blockers
CN107074909B (zh) * 2014-09-30 2020-11-27 深圳华大基因科技有限公司 芋螺毒素多肽κ-CPTx-btl01、其制备方法及应用
WO2016049869A1 (zh) * 2014-09-30 2016-04-07 深圳华大基因科技有限公司 芋螺毒素多肽κ-CPTx-bt102、其制备方法及应用
WO2016049873A1 (zh) * 2014-09-30 2016-04-07 深圳华大基因科技有限公司 芋螺毒素多肽κ-CPTx-btl03、其制备方法及应用
CN107001416B (zh) 2014-12-26 2021-01-15 深圳华大生命科学研究院 芋螺毒素肽κ-CPTx-btl04、其制备方法及应用
WO2016101276A1 (zh) * 2014-12-26 2016-06-30 深圳华大基因研究院 芋螺毒素肽κ-CPTx-btl03、其制备方法及应用
EP3239168B1 (de) * 2014-12-26 2021-07-14 BGI Shenzhen Derivat des conotoxinpeptid-kappa-cptx-btl02, herstellungsverfahren dafür und verwendung davon
EP3239169B1 (de) * 2014-12-26 2024-04-17 BGI Agricultural and Circular Economic Tech Co., Ltd. Conotoxinpeptid -cptx-btl05, herstellungsverfahren dafür und verwendungen davon
WO2016101274A1 (zh) * 2014-12-26 2016-06-30 深圳华大基因研究院 芋螺毒素肽κ-CPTx-btl01、其制备方法及应用
CN114262370B (zh) * 2021-12-16 2023-07-14 海南医学院 一种紫点海葵多肽毒素Hc-GQ及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447356A (en) * 1981-04-17 1984-05-08 Olivera Baldomero M Conotoxins
US5051403A (en) * 1989-11-22 1991-09-24 Neurex Corporation Method of treating ischemia-related neuronal damage
US5189020A (en) * 1989-11-22 1993-02-23 Neurex Corporation Method of reducing neuronal damage using omega conotoxin peptides
US5264371A (en) * 1989-11-22 1993-11-23 Neurex Corporation Screening method for neuroprotective compounds
AU3074592A (en) * 1991-11-12 1993-06-15 Neurex Corporation Compositions for delayed treatment of ischemia-related neuronal damage
WO1993013128A1 (en) * 1991-12-30 1993-07-08 Neurex Corporation Methods of producing analgesia and enhancing opiate analgesia
US5432155A (en) * 1993-06-29 1995-07-11 The Salk Institute For Biological Studies Conotoxins I
US5514774A (en) * 1993-06-29 1996-05-07 University Of Utah Research Foundation Conotoxin peptides
US5589340A (en) * 1993-06-29 1996-12-31 University Of Utah Research Foundation Process and primers for identifying nucleic acids encoding A-lineage conotoxin peptides

Also Published As

Publication number Publication date
US5672682A (en) 1997-09-30
AU2069097A (en) 1997-10-10
JP2001500474A (ja) 2001-01-16
WO1997034925A1 (en) 1997-09-25
DE69731097T2 (de) 2005-02-17
ATE278708T1 (de) 2004-10-15
ES2232861T3 (es) 2005-06-01
EP0922055A1 (de) 1999-06-16
EP0922055B1 (de) 2004-10-06
EP0922055A4 (de) 2002-01-23
CA2248710A1 (en) 1997-09-25
JP3953110B2 (ja) 2007-08-08
CA2248710C (en) 2007-06-12
AU724408B2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
DE69731097D1 (de) Conotoxin peptid pviia
Behrens et al. Biochemistry of the protein hormones
EP0525838A3 (de) Analogen von Wachstum-Hormon-befreundem Hormon
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
BR9708911A (pt) Composto fragmento de peptídeo processo par tratar uma doença em um paciente em necessidade de terapia antioangiogênese composição polinucleotídeo único ou de duplo-filamento isolado vetor e processo para produzir um fragmento de peptídeo de kringle 5 ou proteína de fusão de kringle 5 solúvel
CA2071875A1 (en) Recombinant human factor viii derivative
ES526201A0 (es) Un procedimiento para preparar un peptido que tiene influencia sobre la funcion de la glandula pituitaria
DE69838143D1 (de) Antimikrobielle peptide
KR930701483A (ko) Grf (쥐이알에프) 유사체 xi
DE68927379D1 (de) Plättchen blockierende peptide
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
ES2054365T3 (es) Inhibicion de la via de la regla del n final en celulas vivas.
ATE280827T1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
DE69615026T2 (de) Ein verbessertes peptid, immunogene zusammensetzung und impfstoff oder medizinische präparate, eine methode zur immunisierung von tieren gegen das hormon lhrh und analoge des lhrh-tendem-repeat-peptid und deren verwendung als impfstoff
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
JPH06192298A (ja) 新規機能性ペプチド
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
FR2766190B1 (fr) Nouveaux peptides et polypeptides utiles dans la regeneration du systeme nerveux
NZ331771A (en) Lytic peptides with amphipathic alpha helices and positively charged N- or C-terminal, methods of activation/inactivation, compositions and methods of treatment are also included
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
Terlau et al. Conotoxin peptide PVIIA
JP2759457B2 (ja) 抗腫瘍性蛋白質
DE1518343A1 (de) Verfahren zur Herstellung eledoisinwirksamer Undekapeptide

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSC

Owner name: UNIVERSITY OF UTAH RESEARCH FOUNDATION, SALT LAKE

8364 No opposition during term of opposition